Support teaching, research, and patient care.
Mitchell (Mitch) R. Lunn, MD, MAS, FACP, FASN (he/him/his) is an Associate Professor of Medicine (Nephrology) and of Epidemiology and Population Health at Stanford University School of Medicine. Dr. Lunn consults on hospitalized patients with renal diseases, electrolyte abnormalities, and acid-base disturbances at Stanford Hospital.Dr. Lunn is a physician-scientist investigating sexual and gender minority (SGM) health and utilizing existing and emerging technologies to characterize the health and well-being of these underrepresented and vulnerable populations. SGM people – which primarily includes members of the lesbian, gay, bisexual, transgender, and queer (LGBTQ+) communities – face numerous health and healthcare disparities. Dr. Lunn’s work focuses on improving understanding of the factors that positively and negatively influence SGM health including research on SGM health disparities, SGM societal experiences, provider education about SGM health, and institutional climate towards SGM people. Dr. Lunn is the co-director of The PRIDE Study (pridestudy.org), a national, online, prospective, longitudinal general health cohort study (launched May 2017) of over 28,000 SGM adults. The PRIDE Study’s state-of-the-art web-based research platform enables robust participant recruitment, cohort management, real-time cohort statistics, comprehensive survey administration, facile deployment of studies to cohort segments, and linkage with other health data sources. Dr. Lunn is also the co-director of PRIDEnet, a participant-powered research network of SGM people that engages SGM communities at all stages of the biomedical research process: research question generation and prioritization, study design, recruitment, participation, data analysis, and results dissemination. PRIDEnet accomplishes its goals through a highly active Participant Advisory Committee and a Community Partner Consortium comprised of ~32 SGM-serving health centers, community centers, and service/advocacy organizations across the country. Dr. Lunn mentors research trainees at all levels from undergraduate students to junior faculty members.Dr. Lunn earned a Bachelor of Science degree in biology and French with highest thesis honors from Tufts University in 2004, a Doctor of Medicine degree from Stanford University School of Medicine in 2010, and a Master’s in Advanced Studies degree in Clinical Research from the University of California, San Francisco (UCSF) in 2017. He completed internal medicine internship and residency training at Brigham and Women’s Hospital in 2013 and nephrology fellowship at UCSF in 2016. Dr. Lunn maintains board certification in internal medicine, nephrology, and clinical informatics.
Project RESIST: Increasing Resistance to Tobacco Marketing Among Young Adult Sexual Minority Women Using Inoculation Message Approaches
Project RESIST is an R01 study funded by NCI focused on determining the effects of using
culturally tailored inoculation approaches to increase resilience to tobacco marketing
influences among young adult sexual minority women ages 18-30 and incorporates critical
stakeholder inputs that support later adoption and implementation. The study team is
utilizing formative research to design and pre-test anti-smoking messages and two national
longitudinal online survey experiments.
Stanford is currently not accepting patients for this trial.
For more information, please contact Mitchell Lunn, MD, MAS, FACP, FASN, 650-725-7783.
View full details